CTLA-4 expression on tregs is needed for suppression of autoimmune uveitis

被引:0
作者
Minjun Ahn [1 ]
John Dostal [1 ]
Priya Hegde [1 ]
Darren J. Lee [1 ]
机构
[1] University of Massachusetts Chan Medical School,Department of Ophthalmology and Visual Sciences
关键词
Autoimmune uveitis; Ocular immune privilege; Treg cells; CTLA-4;
D O I
10.1038/s41598-025-02816-z
中图分类号
学科分类号
摘要
Uveitis is a leading cause of blindness in the world and autoimmune uveitis is an ocular tissue specific autoimmune disease. Utilizing experimental autoimmune uveitis (EAU), we can interrogate different immune responses in the mouse that are relevant to the human disease. cytotoxic T-lymphocyte antigen 4 (CTLA-4) is an immune checkpoint molecule that has different roles depending on the target tissue. In this work we investigate the role of CTLA-4 on CD4 T cells in ocular tissue during EAU. We find that CTLA-4 is needed for both the severity of disease but also timely resolution of disease. Regulatory T cells (Tregs) that emerge in the spleen during resolution of EAU require CTLA-4 to suppress disease, but ocular Tregs that emerge in the eye do not require CTLA-4 to suppress disease. This report provides an additional understanding of CTLA-4 on Tregs that is specific for ocular tissue. The implications of this work are that circulating Tregs in uveitis patients may require CTLA-4 to suppress ocular inflammation but once in the eye the function of CTLA-4 is dispensable. 
引用
收藏
相关论文
共 50 条
  • [41] Molecular cloning and expression of feline CD28 and CTLA-4 cDNA
    Choi, IS
    Hash, SM
    Collisson, EW
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2000, 76 (1-2) : 45 - 59
  • [42] Enhancement of antitumor immunity by combination of anti-CTLA-4 antibody and radioimmunotherapy through the suppression of Tregs
    Son, Cheol-Hun
    Bae, Jaeho
    Lee, Hong-Rae
    Yang, Kwangmo
    Park, You-Soo
    ONCOLOGY LETTERS, 2017, 13 (05) : 3781 - 3786
  • [43] MiR-155 controls follicular Treg cell-mediated humoral autoimmune intestinal injury by inhibiting CTLA-4 expression
    Chao, Gao
    Li, Xiaoli
    Ji, Yahong
    Zhu, Ying
    Li, Na
    Zhang, Nana
    Feng, Zunyong
    Niu, Min
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 71 : 267 - 276
  • [44] Disorders of CTLA-4 expression, how they lead to CVID and dysregulated immune responses
    Sun, Di
    Heimall, Jennifer
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 19 (06) : 578 - 585
  • [45] Expression and functional significance of CTLA-4, a negative regulator of T cell activation
    Kosmaczewska, A
    Ciszak, L
    Bocko, D
    Frydecka, I
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2001, 49 (01) : 39 - 46
  • [46] Association of CTLA-4 Polymorphisms with Improved Overall Survival in Melanoma Patients Treated with CTLA-4 Blockade: A Pilot Study
    Queirolo, P.
    Morabito, A.
    Laurent, S.
    Lastraioli, S.
    Piccioli, P.
    Ascierto, P. A.
    Gentilcore, G.
    Serra, M.
    Marasco, A.
    Tornari, E.
    Dozin, B.
    Pistillo, M. P.
    CANCER INVESTIGATION, 2013, 31 (05) : 336 - 345
  • [47] Expression of CTLA-4 (CD152) on human medullary CD4+ thymocytes
    Castan, J
    Klauenberg, U
    Kalmar, P
    Fleischer, B
    Broker, BM
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1998, 187 (01) : 49 - 52
  • [48] CTLA-4 gene in the pathogenesis of Graves' disease
    Yanagawa, T
    Kouki, T
    DeGroot, LJ
    GENETICS OF COMPLEX THYROID DISEASES, 2002, : 103 - 107
  • [49] Meta-Analysis of the Genetic Association between PTPN22 and CTLA-4 Variants and Risk of Uveitis
    Zhang, Jun
    Zhou, Peng
    Hu, Shuqiong
    Qi, Jian
    OPHTHALMIC RESEARCH, 2022, 65 (03) : 264 - 275
  • [50] CTLA-4 and CVID: Analysis of USIDNET Patients
    Ghannam, Sara
    McDonnell, John
    Rotz, Seth
    Fernandez, James
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (SUPPL 1) : S100 - S101